AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. UHT
  4. [8-K] Universal Health AG真人官方ty Income Trust Reports Material Event

[8-K] Universal Health AG真人官方ty Income Trust Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On 28 Jul 2025, TSSP Sub-Fund HoldCo, LLC and its managing member Alan Waxman jointly filed a Schedule 13G disclosing passive ownership in Caris Life Sciences, Inc. ("CAI") as of 30 Jun 2025.

  • TSSP Sub-Fund HoldCo: 23,166,128 shares (8.3 % of the 277,932,779 outstanding).
  • Alan Waxman: deemed beneficial owner of 24,385,399 shares (8.8 %) through control of HoldCo and related Sixth Street vehicles.
  • Shares are distributed across five entities including Barnett Equity Holdings, Sixth Street Specialty Lending Inc. and related investment LLCs.

Both filers report zero sole and shared voting/dispositive power over the respective share counts; ownership is reported under Rule 13d-1(c) as a passive investment. No additional transactions, changes in control, or certifications were disclosed.

Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, dichiarando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
  • Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
  • Le azioni sono distribuite tra cinque entit脿, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.

Entrambi i dichiaranti riportano zero poteri di voto/disposizione individuali e condivisi sulle rispettive azioni; la propriet脿 猫 segnalata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state comunicate ulteriori transazioni, cambi di controllo o certificazioni.

El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G divulgando una participaci贸n pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 acciones (8,3% de las 277.932.779 en circulaci贸n).
  • Alan Waxman: considerado propietario beneficiario de 24.385.399 acciones (8,8%) a trav茅s del control de HoldCo y veh铆culos relacionados de Sixth Street.
  • Las acciones est谩n distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversi贸n relacionadas.

Ambos declarantes reportan cero poderes de voto/disposici贸n individuales y compartidos sobre las acciones respectivas; la propiedad se reporta bajo la Regla 13d-1(c) como una inversi贸n pasiva. No se divulgaron transacciones adicionales, cambios en el control ni certificaciones.

2025雲� 7鞗� 28鞚�, TSSP Sub-Fund HoldCo, LLC鞕� 攴� 甏�毽� 氅る矂鞚� Alan Waxman鞚� 2025雲� 6鞗� 30鞚� 旮办 Caris Life Sciences, Inc.("CAI")鞐� 雽�頃� 靾橂彊鞝� 靻岇湢甓岇潉 瓿店皽頃橂姅 Schedule 13G毳� 瓿惦彊 鞝滌稖頄堨姷雼堧嫟.

  • TSSP Sub-Fund HoldCo: 23,166,128欤� (齑� 277,932,779欤� 欷� 8.3%).
  • Alan Waxman: HoldCo 氚� 甏�霠� Sixth Street 瓿勳棿靷ゼ 韱淀暅 24,385,399欤�(8.8%)鞚� 鞁れ鞝� 靻岇湢鞛愲 臧勳＜霅╇媹雼�.
  • 欤检嫕鞚� Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 氚� 甏�霠� 韴瀽 LLC毳� 韽暔頃� 雼れ劘 臧� 氩曥澑鞐� 攵勳偘霅橃柎 鞛堨姷雼堧嫟.

鞏� 鞝滌稖鞛愲姅 臧侁皝鞚� 欤检嫕鞐� 雽�頃� 雼弲 氚� 瓿惦彊 鞚橁舶甓�/觳橂秳甓岇澊 鞝勴榾 鞐嗢潓鞚� 氤搓碃頄堨溂氅�, 靻岇湢甓岇潃 Rule 13d-1(c)鞐� 霐半澕 靾橂彊鞝� 韴瀽搿� 鞁犼碃霅橃棃鞀惦媹雼�. 於旉皜 瓯半灅, 歆�氚瓣秾 氤�瓴� 霕愲姅 鞚胳 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement d茅pos茅 un Schedule 13G divulguant une participation passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.

  • TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 actions en circulation).
  • Alan Waxman : consid茅r茅 comme b茅n茅ficiaire effectif de 24 385 399 actions (8,8 %) par le contr么le de HoldCo et des entit茅s li茅es de Sixth Street.
  • Les actions sont r茅parties entre cinq entit茅s, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d鈥檌nvestissement associ茅es.

Les deux d茅clarants rapportent aucun pouvoir de vote/disposition exclusif ou 辫补谤迟补驳茅 sur les actions concern茅es ; la propri茅t茅 est d茅clar茅e selon la r猫gle 13d-1(c) comme un investissement passif. Aucune transaction suppl茅mentaire, changement de contr么le ou certification n鈥檃 茅t茅 divulgu茅e.

Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und ihr gesch盲ftsf眉hrendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie den passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.

  • TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
  • Alan Waxman: gilt als wirtschaftlich Berechtigter von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und verwandten Sixth Street Gesellschaften.
  • Die Aktien sind auf f眉nf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verwandte Investment-LLCs.

Beide Einreicher berichten 眉ber keine alleinigen und keine gemeinsamen Stimm- oder Verf眉gungsrechte 眉ber die jeweiligen Aktienanzahlen; das Eigentum wird gem盲脽 Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine weiteren Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.

Positive
  • Sixth Street-affiliated investors now hold an 8.8 % passive stake in CAI, adding a prominent institutional backer to the shareholder base.
Negative
  • None.

Insights

TL;DR: Sixth Street affiliates reveal ~9 % passive stake in CAI; material for ownership mix but no control intent signaled.

The Schedule 13G indicates that Sixth Street鈥搈anaged entities, via TSSP Sub-Fund HoldCo, accumulated 23.2 m CAI shares, while managing member Alan Waxman is deemed to control 24.4 m shares. At 8.3-8.8 % of outstanding stock, this represents a significant minority holding that must be reported but remains below activism thresholds. Because the filing is on Form 13G (not 13D), it signals no current intent to influence management, suggesting a passive, possibly credit-linked or crossover equity position typical of Sixth Street. From a valuation standpoint, new institutional support can tighten the float and may improve liquidity. However, absent any transactional detail or future plans, the disclosure is largely informational; fundamental outlook for CAI is unchanged.

Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, dichiarando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
  • Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
  • Le azioni sono distribuite tra cinque entit脿, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.

Entrambi i dichiaranti riportano zero poteri di voto/disposizione individuali e condivisi sulle rispettive azioni; la propriet脿 猫 segnalata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state comunicate ulteriori transazioni, cambi di controllo o certificazioni.

El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G divulgando una participaci贸n pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 acciones (8,3% de las 277.932.779 en circulaci贸n).
  • Alan Waxman: considerado propietario beneficiario de 24.385.399 acciones (8,8%) a trav茅s del control de HoldCo y veh铆culos relacionados de Sixth Street.
  • Las acciones est谩n distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversi贸n relacionadas.

Ambos declarantes reportan cero poderes de voto/disposici贸n individuales y compartidos sobre las acciones respectivas; la propiedad se reporta bajo la Regla 13d-1(c) como una inversi贸n pasiva. No se divulgaron transacciones adicionales, cambios en el control ni certificaciones.

2025雲� 7鞗� 28鞚�, TSSP Sub-Fund HoldCo, LLC鞕� 攴� 甏�毽� 氅る矂鞚� Alan Waxman鞚� 2025雲� 6鞗� 30鞚� 旮办 Caris Life Sciences, Inc.("CAI")鞐� 雽�頃� 靾橂彊鞝� 靻岇湢甓岇潉 瓿店皽頃橂姅 Schedule 13G毳� 瓿惦彊 鞝滌稖頄堨姷雼堧嫟.

  • TSSP Sub-Fund HoldCo: 23,166,128欤� (齑� 277,932,779欤� 欷� 8.3%).
  • Alan Waxman: HoldCo 氚� 甏�霠� Sixth Street 瓿勳棿靷ゼ 韱淀暅 24,385,399欤�(8.8%)鞚� 鞁れ鞝� 靻岇湢鞛愲 臧勳＜霅╇媹雼�.
  • 欤检嫕鞚� Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 氚� 甏�霠� 韴瀽 LLC毳� 韽暔頃� 雼れ劘 臧� 氩曥澑鞐� 攵勳偘霅橃柎 鞛堨姷雼堧嫟.

鞏� 鞝滌稖鞛愲姅 臧侁皝鞚� 欤检嫕鞐� 雽�頃� 雼弲 氚� 瓿惦彊 鞚橁舶甓�/觳橂秳甓岇澊 鞝勴榾 鞐嗢潓鞚� 氤搓碃頄堨溂氅�, 靻岇湢甓岇潃 Rule 13d-1(c)鞐� 霐半澕 靾橂彊鞝� 韴瀽搿� 鞁犼碃霅橃棃鞀惦媹雼�. 於旉皜 瓯半灅, 歆�氚瓣秾 氤�瓴� 霕愲姅 鞚胳 靷暛鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement d茅pos茅 un Schedule 13G divulguant une participation passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.

  • TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 actions en circulation).
  • Alan Waxman : consid茅r茅 comme b茅n茅ficiaire effectif de 24 385 399 actions (8,8 %) par le contr么le de HoldCo et des entit茅s li茅es de Sixth Street.
  • Les actions sont r茅parties entre cinq entit茅s, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d鈥檌nvestissement associ茅es.

Les deux d茅clarants rapportent aucun pouvoir de vote/disposition exclusif ou 辫补谤迟补驳茅 sur les actions concern茅es ; la propri茅t茅 est d茅clar茅e selon la r猫gle 13d-1(c) comme un investissement passif. Aucune transaction suppl茅mentaire, changement de contr么le ou certification n鈥檃 茅t茅 divulgu茅e.

Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und ihr gesch盲ftsf眉hrendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie den passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.

  • TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
  • Alan Waxman: gilt als wirtschaftlich Berechtigter von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und verwandten Sixth Street Gesellschaften.
  • Die Aktien sind auf f眉nf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verwandte Investment-LLCs.

Beide Einreicher berichten 眉ber keine alleinigen und keine gemeinsamen Stimm- oder Verf眉gungsrechte 眉ber die jeweiligen Aktienanzahlen; das Eigentum wird gem盲脽 Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine weiteren Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.

false000079878300007987832025-07-282025-07-28

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 28, 2025

UNIVERSAL HEALTH REALTY INCOME TRUST

(Exact name of Registrant as Specified in Its Charter)

Maryland

1-9321

23-6858580

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

Universal Corporate Center

367 South Gulph Road

King of Prussia, Pennsylvania

19406

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (610) 265-0688

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

 

Trading Symbol(s)

 

Name of each exchange on which registered

Shares of beneficial interest, $0.01 par value

 

UHT

 

New York Stock Exchange

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 2.02 Results of Operations and Financial Condition.

On July 28, 2025, the Trust made its second quarter, 2025 earnings release. A copy of the Trust’s press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

Number

Description

 99.1

Press release dated July 28, 2025.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

Exhibit Index

 

Exhibit

Number

Description

 99.1

Press release dated July 28, 2025.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

UNIVERSAL HEALTH REALTY INCOME TRUST

Date: July 28, 2025

By:

/s/ Charles F. Boyle

Name:

Charles F. Boyle

Title:

Senior Vice President and Chief Financial Officer

 

Source:

FAQ

Who filed the Schedule 13G for Caris Life Sciences (CAI)?

TSSP Sub-Fund HoldCo, LLC and its managing member Alan Waxman filed jointly.

How many CAI shares do the reporting persons own?

HoldCo reports 23,166,128 shares; Alan Waxman is deemed to own 24,385,399 shares.

What percentage of Caris Life Sciences鈥� outstanding stock is represented?

HoldCo owns 8.3 %; Alan Waxman controls 8.8 % of the 277,932,779 shares outstanding.

Is the stake considered passive or activist?

The filing is on Schedule 13G under Rule 13d-1(c), indicating a passive investment.

Under which CUSIP number was the filing made?

The filing references CUSIP 141252107.

When is the ownership date relevant to the filing?

Ownership is reported as of 30 June 2025.
Stock UHT logo
Universal Health

NYSE:UHT

UHT Rankings

#4152 Ranked by Market Cap
#393 Ranked by Dividends

UHT Latest News

Jul 28, 2025
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2025
Jul 28, 2025
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2025, AND INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST
Jun 11, 2025
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE
Apr 28, 2025
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS
Apr 28, 2025
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2025 FIRST QUARTER FINANCIAL RESULTS

UHT Stock Data

570.68M
12.71M
8.08%
64.41%
2.22%
REIT - Healthcare Facilities
AG真人官方 Estate Investment Trusts
United States
KING OF PRUSSIA